On Monday, Qualcomm raised concerns about the European Union’s ongoing antitrust investigation during hearings before the European Union’s second-highest court. They argued that law enforcement actions were being taken without any evidence of anticompetitive behavior.
Qualcomm is at the European General Court fighting a 242 million euro ($259 million) fine for abusing its dominance in the chip market handed down by the EU, which claims Qualcomm sold chipsets below cost to illegally undercut competitors.
“Chronic mismanagement and blatant prosecutorial bias” is how Miguel Rato, one of Qualcomm’s lawyers, characterized the EU’s case against the company.
The investigation, which began in 2015, revealed potential antitrust violations occurring between 2009 and 2011. At the time, Brussels claims, Qualcomm was deeply concerned about startup rival Icera, which was producing the sets of electronic components for now nearly obsolete technology called “dongles” that allow tablets and laptops to connect to Wi-Fi.
Read more: US Chip Maker Qualcomm Asks EU Court To Overturn Antitrust Fine
The practice Qualcomm is accused of, known as predatory pricing, involves selling products at a steeply discounted price to block rivals from selling their own goods.
The European Commission asserts that over a span of several years, Qualcomm supplied an advanced chipset to the Chinese telecom companies ZTE and Huawei at a discounted cost. The two firms reportedly together made up over 50 percent of the chipset customer market.
Qualcomm contends this case has gone through numerous managers, causing hindrances due to delayed evidence and entropy. Additionally, ZTE is reported to have stated that it was unable to provide any more information concerning the sales as those previously entailed in the matter are no longer employed by the company.
“It is a great pity to conclude that ZTE cannot provide the information,” the partially state-owned company said in an email read out in court Monday by Qualcomm’s counsel.
Featured News
Judge Appoints Law Firms to Lead Consumer Antitrust Litigation Against Apple
Dec 22, 2024 by
CPI
Epic Health Systems Seeks Dismissal of Antitrust Suit Filed by Particle Health
Dec 22, 2024 by
CPI
Qualcomm Secures Partial Victory in Licensing Dispute with Arm, Jury Splits on Key Issues
Dec 22, 2024 by
CPI
Google Proposes Revised Revenue-Sharing Limits Amid Antitrust Battle
Dec 22, 2024 by
CPI
Japan’s Antitrust Authority Expected to Sanction Google Over Monopoly Practices
Dec 22, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand